Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Inspira signs OEM agreement with Terumo Cardiovascular

admin by admin
December 29, 2022
in News


Inspira Technologies (Nasdaq:INN) announced today that it signed an exclusive OEM agreement with Terumo Cardiovascular.

In a news release, Inspira called Terumo Cardiovascular “experts” in oxygenation systems, heart-lung machines and monitoring systems. The agreement covers the manufacture of a flow mechanism for integration into Inspira’s products. The company designed these products for use in the extracorporeal circulation of blood during oxygenation.

The agreement may extend to integration into the Inspira ART system for acute respiratory care. ART boosts oxygen saturation levels in minutes using small volumes of blood. Inspira designed it to treat patients while awake and breathing spontaneously. This reduces the need for invasive mechanical ventilation.

“This is a very important agreement for the company, and we believe that it is in line with our strategy towards developing collaborations with the largest medical device companies to join in on our journey to market,” said Joe Hayon, Inspira co-founder and president.

Terumo Cardiovascular represents a division of Terumo Corporation. Terumo operates in more than 160 countries and regions across the globe. It provides over 50,000 products and services to patients in a variety of medical settings.



Source link

Previous Post

A genome-based comparison of SARS-CoV-2 XBB recombinant and its parental lineage

Next Post

Study identified factors that helped the Alaskan capital mitigate COVID-19’s impact on residents

Next Post

Study identified factors that helped the Alaskan capital mitigate COVID-19's impact on residents

Recommended

Researchers unveil new methods for DNA mosaic recognition

2 weeks ago

FDA hits Olympus with warning letters after factory inspections

3 weeks ago

Clippard releases newest series of ES electronic valves

5 months ago

FDA posts medtech production and quality software guidance draft

4 months ago

What’s next for Medtronic RDN after Spyral trial ‘surprise’?

3 months ago

Could minimally invasive neuromod tackle the opioid epidemic?

2 months ago

Medical-Writers-(-white-)

© 2022 Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.